Clinical Trial Update: Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nivolumab plus ipilimumab with radiation in metastatic pancreatic cancer is currently active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING